+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Topical Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Topical Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083952
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drugs Market grew from USD 16.86 billion in 2024 to USD 18.58 billion in 2025. It is expected to continue growing at a CAGR of 9.74%, reaching USD 29.46 billion by 2030.

A Holistic Overview of the Topical Drugs Market Landscape

The topical drugs market has undergone remarkable evolution in recent years, driven by rapid innovations in formulation technologies, shifting patient demographics, and an increasing demand for targeted therapeutic solutions. As chronic skin conditions and pain management needs rise globally, stakeholders are seeking more effective, patient-centric products that offer improved efficacy and safety profiles. This landscape is further complicated by evolving regulatory frameworks, heightened scrutiny on opioid analgesics, and an expansion of application areas beyond traditional dermatology into cosmetics and infection control. Against this backdrop, industry leaders must navigate a complex interplay of scientific advancements, competitive pressures, and macroeconomic forces to capitalize on emerging opportunities. This executive summary sets the stage for a thorough exploration of transformative market shifts, the implications of forthcoming trade policies, and actionable insights designed to inform strategic decision-making.

Transformative Shifts Redefining the Topical Drugs Industry

Innovation pipelines and evolving healthcare priorities have triggered transformative shifts that are redefining market boundaries. The integration of novel drug delivery systems, including nanocarrier-based creams and gel formulations, has unlocked new therapeutic potentials, particularly in the controlled release of analgesics and anti-infective agents. Concurrently, a broadening of application areas into skin lightening, wrinkle reduction, and advanced wound care has expanded the target patient pool, creating cross-segment growth avenues.

Moreover, heightened regulatory scrutiny on opioid analgesics has accelerated investment in non-opioid alternatives, driving a surge in research on topical non-steroidal anti-inflammatory drugs (NSAIDs) and innovative antipruritic solutions. Dermatological treatments for chronic conditions such as psoriasis and eczema have also leveraged biologically inspired corticosteroid formulations, resulting in enhanced patient adherence and reduced systemic side effects. These converging forces-technological breakthroughs, regulatory realignment, and expanded indications-underscore a market in flux, where agility and scientific rigor will distinguish leading players from laggards.

Understanding the 2025 US Tariffs and Their Cumulative Impact

The introduction of new tariff structures in the United States, scheduled for implementation in 2025, is poised to exert a cumulative impact across the topical drugs supply chain. Raw material costs for active pharmaceutical ingredients sourced internationally are expected to rise, exerting upward pressure on manufacturing expenses and potentially compressing profit margins. Manufacturers relying on antibacterial and antiviral excipients from key export markets will face recalibrated cost models, necessitating strategic sourcing realignments and increased localization of supply chains.

Importers of finished formulations may also experience elevated duties, prompting distributors to reevaluate pricing strategies and contractual terms with healthcare providers. Over time, these changes could drive consolidation among smaller domestic producers, while larger firms with diversified sourcing networks and scale economies may fortify their competitive positions. In response, agile organizations will leverage predictive analytics to forecast input cost variances, optimize ingredient procurement, and implement dynamic pricing mechanisms that preserve market share without compromising accessibility.

In-Depth Segmentation Analysis Unveiling Market Niches

Segmentation insights reveal nuanced opportunities across therapeutic classes, application areas, formulation types, end-user categories, and distribution channels. Based on therapeutic class, the market encompasses analgesics, anti-infective drugs, anti-inflammatory drugs, and antipruritics, with subsegments distinguishing non-opioid from opioid analgesics, antibacterials from antifungals and antivirals, corticosteroids from NSAIDs, and calamine lotion from topical antihistamines. When considering application area, key domains include cosmetics, dermatology, infection prevention, and pain management, each further segmented into functions such as skin lightening, acne treatment, viral infection control, and musculoskeletal pain relief.

Formulation type segmentation highlights creams, gels, lotions, and ointments, distinguishing between healing and moisturizing creams, alcohol-based and water-based gels, emollient and hydroalcoholic lotions, and oleaginous versus petrolatum-based ointments. End users span clinics, homecare settings, and hospitals, with subcategories ranging from general and specialized clinics to assisted and self-application models, as well as inpatient and outpatient care environments. Finally, distribution channels include direct-to-consumer routes through e-commerce and home delivery, pharmacies encompassing both online and retail models, and supermarkets and hypermarkets featuring chain and independent outlets. Together, these segmentation layers offer a comprehensive lens through which to identify high-growth niches and optimize portfolio alignment.

Regional Dynamics Shaping the Topical Drugs Market

Regional dynamics underscore divergent growth trajectories and strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced reimbursement systems and strong R&D ecosystems have cultivated a robust market for non-opioid analgesics and cosmetic dermatology applications, with both North and Latin American markets pursuing localized manufacturing to mitigate tariff-induced cost pressures. Transitioning to Europe, Middle East & Africa, regulatory harmonization under regional entities has facilitated more streamlined approvals for innovative anti-inflammatory and antipruritic agents; however, heterogeneous healthcare infrastructures continue to demand tailored market entry strategies.

Shifting focus to the Asia-Pacific region, rapid urbanization and rising per capita healthcare expenditure have accelerated demand for topical infection prevention solutions, particularly in wound care and viral infection control, while traditional ointment formulations retain cultural acceptance in several countries. As these regions evolve, stakeholders must adapt commercialization models, balancing global best practices with region-specific regulatory, reimbursement, and consumer preference considerations to secure sustainable growth.

Key Players Driving Innovation and Competition

Industry leadership is defined by a blend of innovation, scale, and strategic partnerships. AbbVie Inc. continues to capitalize on its strengths in anti-inflammatory and dermatological therapies, while Almirall, S.A has deepened its presence in cosmetic dermatology through targeted acquisition strategies. Bausch Health Companies Inc. leverages a broad generics portfolio to drive cost-effective pain management solutions, and Bayer AG’s robust R&D pipeline in non-opioid analgesics underscores its commitment to alternative pain therapies.

Meanwhile, collaborative ventures led by Cigna Health and Life Insurance Company are integrating topical therapies into value-based care models, and Concert Pharmaceuticals is pioneering deuterated molecules to enhance drug stability. Eli Lilly and Company and GlaxoSmithKline PLC invest heavily in nanotechnology-driven formulations, whereas Hisamitsu Pharmaceuticals Co. Inc. harnesses transdermal patch expertise for innovative delivery methods. Johnson & Johnson Services, Inc. merges consumer insights with clinical-grade products, while LEO Pharma A/S and Lupin Limited focus on scalable global distribution. Mayne Pharma Group Limited and Mylan N.V. excel at generics commercialization, and Tergus Pharma stands out for contract manufacturing excellence. Together, these companies exemplify diverse pathways to market leadership.

Strategic Imperatives for Industry Leadership and Growth

To navigate this evolving landscape, industry leaders should adopt a series of strategic imperatives. First, invest in advanced formulation technologies, such as lipid-based carriers and microencapsulation, to enhance drug penetration and patient compliance. Second, diversify sourcing networks and consider regional manufacturing hubs to mitigate the effects of tariff volatility and supply chain disruptions. Third, pursue strategic alliances with biotech firms and academic institutions to accelerate R&D, particularly in non-opioid analgesics and antiviral agents.

Additionally, leverage digital platforms and telehealth partnerships to expand direct-to-consumer channels, improving access and gathering real-time patient feedback. Optimize commercialization by aligning product portfolios with regional reimbursement frameworks and tailoring marketing strategies to local cultural nuances. Finally, implement robust data analytics capabilities to monitor market shifts, forecast demand, and inform dynamic pricing models that preserve margins while ensuring affordability.

Concluding Perspectives on Market Trajectories

In conclusion, the topical drugs market stands at a crossroads defined by scientific innovation, complex regulatory environments, and geopolitical influences. Companies that proactively embrace advanced formulation science, adapt supply chains to emerging trade policies, and refine segmentation-based go-to-market strategies will secure competitive advantage. Regional nuances in reimbursement and consumer preferences necessitate agile, localized approaches, while collaboration across the value chain will drive sustainable breakthroughs. By aligning operational excellence with patient-centric innovation, organizations can effectively navigate market uncertainties and capture the growth potential inherent in this dynamic sector.

Market Segmentation & Coverage

This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Analgesics
    • Non-Opioid Analgesics
    • Opioid Analgesics
  • Anti-Infective Drugs
    • Antibacterials
    • Antifungals
    • Antivirals
  • Anti-Inflammatory Drugs
    • Corticosteroids
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Antipruritics
    • Calmine Lotion
    • Topical Antihistamines
  • Cosmetics
    • Skin Lightening
    • Wrinkle Reduction
  • Dermatology
    • Acne
    • Eczema
    • Psoriasis
  • Infection Prevention
    • Viral Infections
    • Wound Care
  • Pain Management
    • Musculoskeletal Pain
    • Post-Traumatic Pain
  • Creams
    • Healing Creams
    • Moisturizing Creams
  • Gels
    • Alcohol-Based Gels
    • Water-Based Gels
  • Lotions
    • Emollient Lotions
    • Hydroalcoholic Lotions
  • Ointments
    • Oleaginous Bases
    • Petrolatum-Based
  • Clinics
    • General Clinics
    • Specialized Clinics
  • Homecare Settings
    • Assisted Application
    • Self-Applied
  • Hospitals
    • Inpatient Care
    • Outpatient Care
  • Direct to Consumer
    • E-commerce Direct Sales
    • Home Deliveries
  • Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Supermarkets and Hypermarkets
    • Chain Supermarkets
    • Independent Stores

This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Topical Drugs Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cigna Health and Life Insurance Company
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • GlaxoSmithkline PLC
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Tergus Pharma

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Drugs Market, by Therapeutic Class
8.1. Introduction
8.2. Analgesics
8.2.1. Non-Opioid Analgesics
8.2.2. Opioid Analgesics
8.3. Anti-Infective Drugs
8.3.1. Antibacterials
8.3.2. Antifungals
8.3.3. Antivirals
8.4. Anti-Inflammatory Drugs
8.4.1. Corticosteroids
8.4.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
8.5. Antipruritics
8.5.1. Calmine Lotion
8.5.2. Topical Antihistamines
9. Topical Drugs Market, by Application Area
9.1. Introduction
9.2. Cosmetics
9.2.1. Skin Lightening
9.2.2. Wrinkle Reduction
9.3. Dermatology
9.3.1. Acne
9.3.2. Eczema
9.3.3. Psoriasis
9.4. Infection Prevention
9.4.1. Viral Infections
9.4.2. Wound Care
9.5. Pain Management
9.5.1. Musculoskeletal Pain
9.5.2. Post-Traumatic Pain
10. Topical Drugs Market, by Formulation Type
10.1. Introduction
10.2. Creams
10.2.1. Healing Creams
10.2.2. Moisturizing Creams
10.3. Gels
10.3.1. Alcohol-Based Gels
10.3.2. Water-Based Gels
10.4. Lotions
10.4.1. Emollient Lotions
10.4.2. Hydroalcoholic Lotions
10.5. Ointments
10.5.1. Oleaginous Bases
10.5.2. Petrolatum-Based
11. Topical Drugs Market, by End-User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Specialized Clinics
11.3. Homecare Settings
11.3.1. Assisted Application
11.3.2. Self-Applied
11.4. Hospitals
11.4.1. Inpatient Care
11.4.2. Outpatient Care
12. Topical Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Direct to Consumer
12.2.1. E-commerce Direct Sales
12.2.2. Home Deliveries
12.3. Pharmacies
12.3.1. Online Pharmacies
12.3.2. Retail Pharmacies
12.4. Supermarkets and Hypermarkets
12.4.1. Chain Supermarkets
12.4.2. Independent Stores
13. Americas Topical Drugs Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Topical Drugs Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Topical Drugs Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Almirall, S.A
16.3.3. Bausch Health Companies Inc.
16.3.4. Bayer AG
16.3.5. Cigna Health and Life Insurance Company
16.3.6. Concert Pharmaceuticals
16.3.7. Eli Lilly and Company
16.3.8. GlaxoSmithkline PLC
16.3.9. Hisamitsu Pharmaceuticals Co. Inc.
16.3.10. Johnson & Johnson Services, Inc.
16.3.11. LEO Pharma A/S
16.3.12. Lupin Limited
16.3.13. Mayne Pharma Group Limited
16.3.14. Mylan N.V.
16.3.15. Tergus Pharma
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TOPICAL DRUGS MARKET MULTI-CURRENCY
FIGURE 2. TOPICAL DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOPICAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OPIOID ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTIBACTERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL DRUGS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CALMINE LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL DRUGS MARKET SIZE, BY TOPICAL ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SKIN LIGHTENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL DRUGS MARKET SIZE, BY WRINKLE REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ACNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL DRUGS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL DRUGS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL DRUGS MARKET SIZE, BY MUSCULOSKELETAL PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOPICAL DRUGS MARKET SIZE, BY POST-TRAUMATIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HEALING CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL DRUGS MARKET SIZE, BY MOISTURIZING CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ALCOHOL-BASED GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL DRUGS MARKET SIZE, BY WATER-BASED GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOPICAL DRUGS MARKET SIZE, BY EMOLLIENT LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HYDROALCOHOLIC LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OLEAGINOUS BASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PETROLATUM-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ASSISTED APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SELF-APPLIED, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OUTPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL TOPICAL DRUGS MARKET SIZE, BY E-COMMERCE DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOME DELIVERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CHAIN SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INDEPENDENT STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 155. CANADA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 156. CANADA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 157. CANADA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 158. CANADA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 159. CANADA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 160. CANADA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 161. CANADA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 162. CANADA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 163. CANADA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 164. CANADA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. CANADA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 166. CANADA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 167. CANADA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 168. CANADA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 169. CANADA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 170. CANADA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. CANADA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. CANADA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 173. CANADA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. CANADA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. CANADA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 176. CANADA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. CANADA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 184. MEXICO TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 186. MEXICO TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 188. MEXICO TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 189. MEXICO TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 190. MEXICO TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 191. MEXICO TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. MEXICO TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. MEXICO TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 199. MEXICO TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 272. CHINA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 273. CHINA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 274. CHINA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 275. CHINA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 276. CHINA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 277. CHINA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 278. CHINA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 279. CHINA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 280. CHINA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 281. CHINA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 282. CHINA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 283. CHINA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 284. CHINA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 285. CHINA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 286. CHINA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 287. CHINA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. CHINA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 289. CHINA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 290. CHINA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. CHINA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. CHINA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 293. CHINA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. CHINA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 295. INDIA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 296. INDIA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 297. INDIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 298. INDIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 299. INDIA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 300. INDIA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 301. INDIA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 302. INDIA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 303. INDIA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 304. INDIA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 305. INDIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 306. INDIA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 307. INDIA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 308. INDIA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 309. INDIA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 310. INDIA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. INDIA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 312. INDIA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 313. INDIA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. INDIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDIA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 316. INDIA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 317. INDIA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 328. INDONESIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 329. INDONESIA TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 330. INDONESIA TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 331. INDONESIA TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 332. INDONESIA TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 333. INDONESIA TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. INDONESIA TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 335. INDONESIA TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 336. INDONESIA TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. INDONESIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. INDONESIA TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 339. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 340. INDONESIA TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 341. JAPAN TOPICAL DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 342. JAPAN TOPICAL DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 343. JAPAN TOPICAL DRUGS MARKET SIZE, BY ANTI-INFECTIVE DRUGS, 2018-2030 (USD MILLION)
TABLE 344. JAPAN TOPICAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 345. JAPAN TOPICAL DRUGS MARKET SIZE, BY ANTIPRURITICS, 2018-2030 (USD MILLION)
TABLE 346. JAPAN TOPICAL DRUGS MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 347. JAPAN TOPICAL DRUGS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 348. JAPAN TOPICAL DRUGS MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 349. JAPAN TOPICAL DRUGS MARKET SIZE, BY INFECTION PREVENTION, 2018-2030 (USD MILLION)
TABLE 350. JAPAN TOPICAL DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 351. JAPAN TOPICAL DRUGS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 352. JAPAN TOPICAL DRUGS MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 353. JAPAN TOPICAL DRUGS MARKET SIZE, BY GELS, 2018-2030 (USD MILLION)
TABLE 354. JAPAN TOPICAL DRUGS MARKET SIZE, BY LOTIONS, 2018-2030 (USD MILLION)
TABLE 355. JAPAN TOPICAL DRUGS MARKET SIZE, BY OINTMENTS, 2018-2030 (USD MILLION)
TABLE 356. JAPAN TOPICAL DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 357. JAPAN TOPICAL DRUGS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 358. JAPAN TOPICAL DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 359. JAPAN TOPICAL DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 360. JAPAN TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. JAPAN TOPICAL DRUGS MARKET SIZE, BY DIRECT TO CONSUMER, 2018-2030 (USD MILLION)
TABLE 362. JAPAN TOPICAL DRUGS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 363. JAPAN TOPICAL DRUGS MARKET SIZE, BY SUPERMARKETS A

Companies Mentioned

  • AbbVie Inc.
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cigna Health and Life Insurance Company
  • Concert Pharmaceuticals
  • Eli Lilly and Company
  • GlaxoSmithkline PLC
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Tergus Pharma

Methodology

Loading
LOADING...

Related Topics

Related Reports

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030 - Product Image

Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Stretch Marks Treatment Market by Treatment Type, Product Type, End-User - Global Forecast 2025-2030 - Product Image

Stretch Marks Treatment Market by Treatment Type, Product Type, End-User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Compounded Topical Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Compounded Topical Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From

About the Ointment Market

The Ointment market within the context of Over the Counter (OTC) Drugs is a large and diverse industry. Ointments are topical medications used to treat a variety of skin conditions, such as eczema, psoriasis, and acne. Ointments are typically composed of a combination of oils, waxes, and other ingredients, and are applied directly to the skin. Ointments are available in a variety of forms, including creams, lotions, and gels. The Ointment market is highly competitive, with a wide range of products available from both large and small companies. Many of the leading Ointment manufacturers are multinational corporations, with products sold in countries around the world. In addition, there are a number of smaller, independent companies that specialize in Ointment products. Some of the leading companies in the Ointment market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Bayer. These companies produce a wide range of Ointment products, including creams, lotions, and gels. Other companies in the Ointment market include CVS, Walgreens, and Rite Aid. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.